The Korea Times
Samsung Biologics said Monday it is participating in the American Association for Cancer Research (AACR) Annual Meeting 2026, showcasing its integrated contract research, development and manufacturing capabilities to prospective clients. The event, held under the theme "Advancing Cancer Science to Save Lives Globally," runs through April 22 at the San Diego Convention Center in California. More than 22,000 oncology researchers and pharmaceutical and biotechnology industry representatives from over 140 countries attend each year. The AACR Annual Meeting is one of three major global oncology conferences, alongside events held by the American Society of Clinical Oncology and the European Society for Medical Oncology. This marks Samsung Biologics' first participation in the AACR Annual Meeting. The company said it viewed the conference — focused on preclinical and early-phase clinical research — as a strategic venue to engage customers at the earliest stages of drug development. Its aim, it said, is to build relationships from initial candidate development through commercial manufacturin
Go to News Site